Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
MARCAINE—Solutions of MARCAINE that do not contain epinephrine may be autoclaved. Autoclave at 15-pound pressure, 121 °C (250 °F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration | Each |
0.25% Contains 2.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1559-10 | 25 mg/10 mL | NDC 0409-1559-18 |
NDC 0409-1559-30 | 75 mg/30 mL | NDC 0409-1559-19 |
NDC 0409-1587-50 | 125 mg/50 mL | NDC 0409-1587-50 |
0.5% Contains 5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1560-10 | 50 mg/10 mL | NDC 0409-1560-18 |
NDC 0409-1560-29 | 150 mg/30 mL | NDC 0409-1560-19 |
NDC 0409-1610-50 | 250 mg/50 mL | NDC 0409-1610-50 |
0.75% Contains 7.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1582-10 | 75 mg/10 mL | NDC 0409-1582-18 |
NDC 0409-1582-29 | 225 mg/30 mL | NDC 0409-1582-19 |
For single-dose vials: Discard unused portion.
MARCAINE with epinephrine 1:200,000 (as bitartrate)—Do not autoclave solutions of MARCAINE that contain epinephrine and protect from light. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration | Each |
0.25% with epinephrine 1:200,000—Contains 2.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1746-10 | 25 mg/10 mL | NDC 0409-1746-70 |
NDC 0409-1746-30 | 75 mg/30 mL | NDC 0409-1746-71 |
NDC 0409-1752-50 | 125 mg/50 mL | NDC 0409-1752-50 |
0.5% with epinephrine 1:200,000—Contains 5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1749-10 | 50 mg/10 mL | NDC 0409-1749-70 |
NDC 0409-1749-29 | 150 mg/30 mL | NDC 0409-1749-71 |
NDC 0409-1755-50 | 250 mg/50 mL | NDC 0409-1755-50 |
For single-dose vials: Discard unused portion.
Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). [See USP Controlled Room Temperature.]
MARCAINE—Solutions of MARCAINE that do not contain epinephrine may be autoclaved. Autoclave at 15-pound pressure, 121 °C (250 °F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration | Each |
0.25% Contains 2.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1559-10 | 25 mg/10 mL | NDC 0409-1559-18 |
NDC 0409-1559-30 | 75 mg/30 mL | NDC 0409-1559-19 |
NDC 0409-1587-50 | 125 mg/50 mL | NDC 0409-1587-50 |
0.5% Contains 5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1560-10 | 50 mg/10 mL | NDC 0409-1560-18 |
NDC 0409-1560-29 | 150 mg/30 mL | NDC 0409-1560-19 |
NDC 0409-1610-50 | 250 mg/50 mL | NDC 0409-1610-50 |
0.75% Contains 7.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1582-10 | 75 mg/10 mL | NDC 0409-1582-18 |
NDC 0409-1582-29 | 225 mg/30 mL | NDC 0409-1582-19 |
For single-dose vials: Discard unused portion.
MARCAINE with epinephrine 1:200,000 (as bitartrate)—Do not autoclave solutions of MARCAINE that contain epinephrine and protect from light. This product is clear and colorless. Do not use the solution if it is discolored or if it contains a precipitate.
Unit of Sale | Concentration | Each |
0.25% with epinephrine 1:200,000—Contains 2.5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1746-10 | 25 mg/10 mL | NDC 0409-1746-70 |
NDC 0409-1746-30 | 75 mg/30 mL | NDC 0409-1746-71 |
NDC 0409-1752-50 | 125 mg/50 mL | NDC 0409-1752-50 |
0.5% with epinephrine 1:200,000—Contains 5 mg bupivacaine hydrochloride per mL. | ||
NDC 0409-1749-10 | 50 mg/10 mL | NDC 0409-1749-70 |
NDC 0409-1749-29 | 150 mg/30 mL | NDC 0409-1749-71 |
NDC 0409-1755-50 | 250 mg/50 mL | NDC 0409-1755-50 |
For single-dose vials: Discard unused portion.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.